BRIEF-Organon Q3 Adjusted EPS USD 1.01 Vs. IBES Estimate USD 0.94

Reuters

2025/11/10

Nov 10 (Reuters) - Organon Q3 adjusted net income USD 263 million vs. IBES estimate USD 245.3 million.

Q3 EPS USD 0.61
Q3 revenue USD 1,602 million vs. IBES estimate USD 1,575 million
Q3 gross margin 53.5%
Q3 net income USD 160 million
Q3 adjusted EBITDA USD 518 million
Q3 adjusted EBITDA margin 32.3%
outlook FY revenue USD 6,200-6,250 million
outlook FY adjusted EBITDA margin 31%

應版權方要求，你需要登入查看該內容

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2582487577"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2582487577\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2582487577?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-10 20:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2582487577","market":"fut","top_or_hot":-1,"title":"BRIEF-Organon Q3 Adjusted EPS USD 1.01 Vs. IBES Estimate USD 0.94","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\">\n<head>\n<meta/>\n<title>BRIEF-Organon Q3 Adjusted EPS USD 1.01 Vs. IBES Estimate USD 0.94</title>\n</head>\n<body>\n<p>Nov 10 (Reuters) - Organon Q3 adjusted net income USD 263 million vs. IBES estimate USD 245.3 million.</p>\n<ul>\n<li>Q3 EPS USD 0.61</li>\n<li>Q3 revenue USD 1,602 million vs. IBES estimate USD 1,575 million</li>\n<li>Q3 gross margin 53.5%</li>\n<li>Q3 net income USD 160 million</li>\n<li>Q3 adjusted EBITDA USD 518 million</li>\n<li>Q3 adjusted EBITDA margin 32.3%</li>\n<li>outlook FY revenue USD 6,200-6,250 million</li>\n<li>outlook FY adjusted EBITDA margin 31%</li>\n</ul>\n</body>\n</html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Organon Q3 Adjusted EPS USD 1.01 Vs. IBES Estimate USD 0.94</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Organon Q3 Adjusted EPS USD 1.01 Vs. IBES Estimate USD 0.94\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-11-10 20:30</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\">\n<head>\n<meta/>\n<title>BRIEF-Organon Q3 Adjusted EPS USD 1.01 Vs. IBES Estimate USD 0.94</title>\n</head>\n<body>\n<p>Nov 10 (Reuters) - Organon Q3 adjusted net income USD 263 million vs. IBES estimate USD 245.3 million.</p>\n<ul>\n<li>Q3 EPS USD 0.61</li>\n<li>Q3 revenue USD 1,602 million vs. IBES estimate USD 1,575 million</li>\n<li>Q3 gross margin 53.5%</li>\n<li>Q3 net income USD 160 million</li>\n<li>Q3 adjusted EBITDA USD 518 million</li>\n<li>Q3 adjusted EBITDA margin 32.3%</li>\n<li>outlook FY revenue USD 6,200-6,250 million</li>\n<li>outlook FY adjusted EBITDA margin 31%</li>\n</ul>\n</body>\n</html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2065171311.SGD","symbol_name":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) ACC","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nPLXF2C551:1","article_id":"2582487577","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2582487577","pubTimestamp":1762777846,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Nov 10  - Organon Q3 adjusted net income USD 263 million vs. IBES estimate USD 245.3 million.Q3 revenue USD 1,602 million vs. IBES estimate USD 1,575 million","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2065171311.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) ACC","LU2065169927.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) ACC","BK4559":"巴菲特持仓","LU2065171402.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) INC","BK4007":"制药","OGN":"Organon & Co","BK4588":"碎股","BK4585":"ETF&股票定投概念","LU2065170008.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) INC"},"translate_title":"简介-Organon第三季度调整后每股收益为1.01美元，而IBES预估为0.94美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OGN":0.9},"content_text":"BRIEF-Organon Q3 Adjusted EPS USD 1.01 Vs. IBES Estimate USD 0.94\n\n\nNov 10 (Reuters) - Organon Q3 adjusted net income USD 263 million vs. IBES estimate USD 245.3 million.\n\nQ3 EPS USD 0.61\nQ3 revenue USD 1,602 million vs. IBES estimate USD 1,575 million\nQ3 gross margin 53.5%\nQ3 net income USD 160 million\nQ3 adjusted EBITDA USD 518 million\nQ3 adjusted EBITDA margin 32.3%\noutlook FY revenue USD 6,200-6,250 million\noutlook FY adjusted EBITDA margin 31%","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"express","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":true,"code":"91000000","status":"200"}}}